Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,618 USD | +1,81% | -0,78% | -54,80% |
Omzet 2024 * | 3K 2,8K | Omzet 2025 * | 2,5 mln. 2,34 mln. | Marktkapitalisatie | 21,78 mln. 20,36 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,57 mln. | Nettowinst (verlies) 2025 * | -77 mln. -71,98 mln. | EV/omzet 2024 * | 7.260 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 8,7 x |
K/w-verhouding 2024 * |
-0,42
x | K/w-verhouding 2025 * |
-0,48
x | Werknemers | 58 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,11% |
Recentste transcriptie over Biora Therapeutics, Inc.
1 dag | +1,81% | ||
1 week | -0,78% | ||
Lopende maand | -44,53% | ||
1 maand | -54,12% | ||
3 maanden | -35,09% | ||
6 maanden | -68,87% | ||
Lopend jaar | -54,80% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 01-05-19 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 49 | 01-06-14 | |
Jeffrey Alter
CHM | Chairman | 61 | 01-01-19 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 08-11-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,6102 | +0,53% | 96 980 |
25-04-24 | 0,607 | -2,08% | 151 521 |
24-04-24 | 0,6199 | -2,99% | 184 411 |
23-04-24 | 0,639 | +5,43% | 383 304 |
22-04-24 | 0,6061 | -1,45% | 160 218 |
uitgestelde koers Nasdaq, 26 april 2024 om 19:05 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-54,80% | 21,78 mln. | |
-1,81% | 103 mld. | |
+0,52% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,52% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,91% | 15,52 mld. | |
+3,76% | 13,86 mld. | |
+35,72% | 12,04 mld. |